Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

Total article views   HTML views PDF downloads Totals
11,431 Dovepress* 7,893+ 1,654 9,547
PubMed Central* 3,538 494 4,032
Totals 11,431 2,148 13,579
*Since 11 April 2019

View citations on PubMed Central and Google Scholar